Lawsuit Alleges Injectafer Caused Phosphate Levels To Drop To Critically Low After Iron Infusion
Plaintiff claims the manufacturers failed to warn about the risk of critically low phosphate levels caused by Injectafer iron infusions.
Plaintiff claims the manufacturers failed to warn about the risk of critically low phosphate levels caused by Injectafer iron infusions.
Researchers warn Injectafer side effects and other iron supplements could lead to a particularly pronounced Vitamin D and calcium deficiency in those with gastrointestinal problems.
Injectafer fared better than the competing IV iron supplements, Dexiron and Feraheme, which were three to eight times more likely to cause anaphylaxis.
Problems after Injectafer infusions may result in severe and life-threatening injuries due to drops in phosphate levels. Monitoring after iron injections plays an important role in reducing the risk.
Each iron infusion reportedly left plaintiff debilitated for days or even months at a time.